FENOFIBRATE

FENOFIBRATE was reported 35986 times

FENOFIBRATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AMAUROSIS FUGAX 230 0.2136
1 PANCREATITIS HAEMORRHAGIC 32 0.0687
2 HIGH DENSITY LIPOPROTEIN DECREASED 160 0.0480
3 URINARY TRACT DISORDER 207 0.0459
4 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 44 0.0414
5 HYPERTRIGLYCERIDAEMIA 225 0.0384
6 BLOOD TRIGLYCERIDES ABNORMAL 32 0.0365
7 HAEMORRHAGIC STROKE 269 0.0344
8 PANCREATITIS RELAPSING 27 0.0330
9 NEPHROGENIC ANAEMIA 144 0.0311
10 GLOMERULAR FILTRATION RATE INCREASED 24 0.0291
11 HYPERPARATHYROIDISM SECONDARY 69 0.0275
12 DIABETIC METABOLIC DECOMPENSATION 37 0.0266
13 REBOUND ACID HYPERSECRETION 70 0.0231
14 OCULAR DISCOMFORT 248 0.0221
15 BLOOD TRIGLYCERIDES INCREASED 363 0.0205
16 PANCREATITIS NECROTISING 47 0.0204
17 GENERALISED OEDEMA 245 0.0198
18 PANCREATITIS ACUTE 419 0.0186
19 STENOSIS 34 0.0181
20 BLOOD BILIRUBIN ABNORMAL 23 0.0180
21 DYSLIPIDAEMIA 91 0.0179
22 METABOLIC SYNDROME 29 0.0176
23 MYOGLOBIN BLOOD INCREASED 26 0.0170
24 MITRAL VALVE DISEASE 29 0.0164
25 HEAD DISCOMFORT 260 0.0147
26 DILATATION VENTRICULAR 30 0.0143
27 ESSENTIAL HYPERTENSION 26 0.0142
28 KIDNEY FIBROSIS 24 0.0138
29 CHRONIC KIDNEY DISEASE 1043 0.0137
30 AORTIC ARTERIOSCLEROSIS 35 0.0136
31 PANCREATITIS CHRONIC 32 0.0135
32 END STAGE RENAL DISEASE 244 0.0134
33 ALTERED STATE OF CONSCIOUSNESS 273 0.0126
34 MUCOSAL DRYNESS 25 0.0124
35 EUGLYCAEMIC DIABETIC KETOACIDOSIS 51 0.0123
36 HYPERTONIC BLADDER 35 0.0121
37 CAROTID ARTERY STENOSIS 42 0.0120
38 BLOOD PRESSURE DIASTOLIC ABNORMAL 30 0.0118
39 CHOLESTATIC LIVER INJURY 26 0.0117
40 RHINALGIA 32 0.0116
41 MYOPATHY 99 0.0115
42 HAEMATEMESIS 290 0.0114
43 ALANINE AMINOTRANSFERASE ABNORMAL 24 0.0114
44 BLOOD LOSS ANAEMIA 25 0.0110
45 DISTRIBUTIVE SHOCK 25 0.0110
46 PHOTOPHOBIA 205 0.0109
47 ORTHOPNOEA 34 0.0107
48 LICHENOID KERATOSIS 24 0.0105
49 HEPATIC FIBROSIS 36 0.0105
50 RHABDOMYOLYSIS 434 0.0104
51 PRESYNCOPE 250 0.0103
52 LEFT VENTRICULAR HYPERTROPHY 44 0.0103
53 CHRONIC SINUSITIS 38 0.0101
54 BLOOD PRESSURE SYSTOLIC ABNORMAL 25 0.0101
55 PARANASAL SINUS DISCOMFORT 38 0.0100
56 BLOOD CHOLESTEROL ABNORMAL 46 0.0099
57 DIPLOPIA 257 0.0099
58 ASCITES 290 0.0099
59 BLOOD CREATININE ABNORMAL 34 0.0098
60 HEPATIC STEATOSIS 179 0.0096
61 HYPERLIPIDAEMIA 113 0.0094
62 HAEMATURIA 321 0.0094
63 DIABETIC NEUROPATHY 46 0.0093
64 NEUTROPHIL COUNT ABNORMAL 26 0.0092
65 BLOOD CREATINE PHOSPHOKINASE INCREASED 262 0.0091
66 DIASTOLIC DYSFUNCTION 28 0.0091
67 IMPAIRED GASTRIC EMPTYING 120 0.0088
68 DUODENITIS 27 0.0088
69 VENTRICULAR ARRHYTHMIA 31 0.0085
70 ACUTE KIDNEY INJURY 1292 0.0084
71 NORMOCHROMIC NORMOCYTIC ANAEMIA 25 0.0083
72 GLYCOSYLATED HAEMOGLOBIN INCREASED 209 0.0083
73 BUNDLE BRANCH BLOCK LEFT 35 0.0082
74 ACCIDENTAL EXPOSURE 34 0.0082
75 NEPHROPATHY 76 0.0081
76 RALES 47 0.0081
77 PANCREATIC CARCINOMA METASTATIC 23 0.0081
78 LEFT VENTRICULAR DYSFUNCTION 54 0.0081
79 ESCHERICHIA URINARY TRACT INFECTION 34 0.0080
80 METABOLIC ENCEPHALOPATHY 24 0.0080
81 HYPERCHOLESTEROLAEMIA 77 0.0080
82 BLOOD PRESSURE DIASTOLIC DECREASED 58 0.0078
83 CYTOLYTIC HEPATITIS 26 0.0078
84 PANCREATITIS 413 0.0078
85 LOW DENSITY LIPOPROTEIN INCREASED 60 0.0077
86 HEPATIC FUNCTION ABNORMAL 287 0.0077
87 SKIN WEEPING 27 0.0076
88 TUBULOINTERSTITIAL NEPHRITIS 141 0.0075
89 HAEMORRHAGIC ANAEMIA 33 0.0075
90 MONOCYTE COUNT INCREASED 27 0.0074
91 HEPATIC NECROSIS 28 0.0074
92 HYPOVOLAEMIC SHOCK 35 0.0073
93 AORTIC VALVE INCOMPETENCE 31 0.0073
94 INTERNATIONAL NORMALISED RATIO INCREASED 206 0.0072
95 RENAL FAILURE 954 0.0072
96 PROSTATOMEGALY 28 0.0071
97 RENAL FAILURE ACUTE 299 0.0070
98 BLOOD MAGNESIUM DECREASED 60 0.0069
99 RENAL INJURY 206 0.0069
100 SYNOVIAL CYST 32 0.0069
101 EYE PAIN 391 0.0069
102 RENAL FUNCTION TEST ABNORMAL 32 0.0069
103 MITRAL VALVE INCOMPETENCE 78 0.0069
104 POTENTIATING DRUG INTERACTION 23 0.0068
105 CARDIO-RESPIRATORY ARREST 282 0.0067
106 VULVOVAGINAL PRURITUS 34 0.0067
107 COMA 318 0.0067
108 BLINDNESS 272 0.0067
109 GLOMERULAR FILTRATION RATE DECREASED 82 0.0067
110 VITAMIN D DECREASED 57 0.0067
111 HEPATIC CYTOLYSIS 85 0.0067
112 SLEEP APNOEA SYNDROME 125 0.0065
113 BLOOD POTASSIUM INCREASED 106 0.0065
114 JAUNDICE CHOLESTATIC 23 0.0065
115 DIABETES MELLITUS INADEQUATE CONTROL 113 0.0064
116 GAMMA-GLUTAMYLTRANSFERASE INCREASED 139 0.0063
117 GLUCOSE TOLERANCE IMPAIRED 37 0.0063
118 TINNITUS 286 0.0062
119 APHTHOUS ULCER 48 0.0062
120 SUSPECTED SUICIDE 29 0.0062
121 DRUG-INDUCED LIVER INJURY 194 0.0062
122 BLOOD CHOLESTEROL INCREASED 285 0.0061
123 ODYNOPHAGIA 36 0.0060
124 OCULAR ICTERUS 26 0.0060
125 UPPER-AIRWAY COUGH SYNDROME 49 0.0059
126 MUSCLE FATIGUE 25 0.0059
127 PANCREATIC DISORDER 29 0.0059
128 LIPASE INCREASED 45 0.0059
129 BLOOD TESTOSTERONE DECREASED 40 0.0058
130 HYPERNATRAEMIA 29 0.0058
131 HYPOMAGNESAEMIA 81 0.0058
132 DERMATITIS EXFOLIATIVE 29 0.0058
133 RENAL CYST 46 0.0058
134 PROTEINURIA 110 0.0058
135 PRE-EXISTING CONDITION IMPROVED 36 0.0058
136 CORONARY ARTERY STENOSIS 29 0.0058
137 DRUG INTERACTION 914 0.0058
138 JAUNDICE 155 0.0058
139 ARTERIOSCLEROSIS CORONARY ARTERY 38 0.0057
140 LYMPHOPENIA 81 0.0057
141 SINUS CONGESTION 77 0.0057
142 HEPATOMEGALY 56 0.0057
143 SHOCK HAEMORRHAGIC 46 0.0056
144 RENAL TUBULAR NECROSIS 55 0.0056
145 ANHEDONIA 144 0.0055
146 PRODUCT ODOUR ABNORMAL 57 0.0054
147 ACUTE CORONARY SYNDROME 45 0.0054
148 ABNORMAL LOSS OF WEIGHT 37 0.0054
149 NASAL DRYNESS 34 0.0054
150 TRICUSPID VALVE INCOMPETENCE 43 0.0054
151 SPLENOMEGALY 63 0.0054
152 RENAL IMPAIRMENT 449 0.0053
153 MYALGIA 905 0.0053
154 MUSCULOSKELETAL CHEST PAIN 82 0.0053
155 INTERVERTEBRAL DISC DEGENERATION 49 0.0053
156 INJECTION SITE EXTRAVASATION 65 0.0053
157 SKIN LACERATION 57 0.0052
158 ACIDOSIS 40 0.0052
159 ELECTROCARDIOGRAM ABNORMAL 41 0.0052
160 LARGE INTESTINE POLYP 36 0.0052
161 BLOOD UREA INCREASED 87 0.0052
162 CHOLELITHIASIS 169 0.0051
163 MYOSITIS 46 0.0051
164 FAECALOMA 28 0.0051
165 MULTIPLE ALLERGIES 40 0.0051
166 SEASONAL ALLERGY 72 0.0051
167 PHOTOSENSITIVITY REACTION 84 0.0051
168 BLOOD CREATININE INCREASED 332 0.0051
169 BLOOD PRESSURE SYSTOLIC INCREASED 99 0.0051
170 HYPERKERATOSIS 28 0.0051
171 LACTIC ACIDOSIS 163 0.0050
172 VITAMIN D DEFICIENCY 49 0.0050
173 ACUTE MYOCARDIAL INFARCTION 148 0.0050
174 CHOLESTASIS 96 0.0050
175 NERVE COMPRESSION 46 0.0050
176 HAEMOGLOBIN ABNORMAL 32 0.0050
177 HYPOVOLAEMIA 29 0.0050
178 PULMONARY TOXICITY 35 0.0049
179 BLOOD GLUCOSE ABNORMAL 91 0.0049
180 SEPSIS 548 0.0049
181 MUSCLE ATROPHY 62 0.0049
182 MENISCUS INJURY 30 0.0049
183 DIVERTICULITIS 134 0.0048
184 RENAL FAILURE CHRONIC 37 0.0048
185 ATRIOVENTRICULAR BLOCK 37 0.0048
186 SPINAL OSTEOARTHRITIS 42 0.0048
187 VULVOVAGINAL BURNING SENSATION 29 0.0047
188 ECONOMIC PROBLEM 72 0.0047
189 POLYP 31 0.0047
190 HYPOKALAEMIA 218 0.0047
191 DIABETIC KETOACIDOSIS 113 0.0047
192 WHITE BLOOD CELL COUNT ABNORMAL 30 0.0047
193 GASTRIC ULCER HAEMORRHAGE 26 0.0047
194 HEPATITIS CHOLESTATIC 28 0.0046
195 BENIGN PROSTATIC HYPERPLASIA 24 0.0046
196 UPPER GASTROINTESTINAL HAEMORRHAGE 78 0.0046
197 ABDOMINAL TENDERNESS 23 0.0046
198 HEPATITIS ACUTE 30 0.0046
199 BACK INJURY 50 0.0046
200 CORONARY ARTERY DISEASE 139 0.0046
201 PRODUCT ADMINISTRATION INTERRUPTED 36 0.0046
202 BLOOD PRESSURE INCREASED 696 0.0045
203 GASTROINTESTINAL HAEMORRHAGE 380 0.0045
204 OSTEOPENIA 69 0.0045
205 FLUSHING 462 0.0045
206 NASAL DISCOMFORT 36 0.0045
207 FAECES SOFT 33 0.0045
208 CHOLECYSTITIS 54 0.0045
209 CORONARY ARTERY OCCLUSION 62 0.0045
210 OBESITY 72 0.0045
211 TACHYCARDIA 400 0.0045
212 FLANK PAIN 42 0.0045
213 BLOOD IRON DECREASED 53 0.0045
214 HYPOPHOSPHATAEMIA 33 0.0045
215 LOWER GASTROINTESTINAL HAEMORRHAGE 33 0.0045
216 NEPHROPATHY TOXIC 50 0.0044
217 PERIPHERAL SENSORY NEUROPATHY 26 0.0044
218 AGRANULOCYTOSIS 82 0.0044
219 BODY HEIGHT DECREASED 47 0.0044
220 INTERVERTEBRAL DISC PROTRUSION 96 0.0044
221 HEPATOCELLULAR INJURY 62 0.0044
222 TOXIC SKIN ERUPTION 44 0.0044
223 ARTERIOSCLEROSIS 41 0.0044
224 URINE OUTPUT DECREASED 38 0.0043
225 LYMPHOEDEMA 30 0.0043
226 ANGIOPATHY 24 0.0043
227 SYNCOPE 426 0.0043
228 HAEMORRHOIDS 83 0.0043
229 DIVERTICULUM 30 0.0042
230 RHINITIS 34 0.0042
231 STENT PLACEMENT 34 0.0042
232 CARDIAC PACEMAKER INSERTION 25 0.0042
233 PROTHROMBIN TIME PROLONGED 25 0.0042
234 SUPRAVENTRICULAR TACHYCARDIA 40 0.0042
235 FALL 1387 0.0042
236 INCONTINENCE 44 0.0042
237 PULMONARY MASS 62 0.0042
238 ASPARTATE AMINOTRANSFERASE INCREASED 220 0.0041
239 ULCER HAEMORRHAGE 28 0.0041
240 PLATELET COUNT ABNORMAL 25 0.0041
241 GASTROOESOPHAGEAL REFLUX DISEASE 332 0.0041
242 METABOLIC ACIDOSIS 131 0.0041
243 INJECTION SITE NODULE 45 0.0041
244 TROPONIN INCREASED 31 0.0041
245 CARPAL TUNNEL SYNDROME 57 0.0041
246 RED BLOOD CELL SEDIMENTATION RATE INCREASED 45 0.0041
247 HEPATITIS 104 0.0041
248 HYPOGLYCAEMIA 197 0.0041
249 CARDIOMYOPATHY 60 0.0041
250 HYPERCALCAEMIA 50 0.0040
251 HEPATIC FAILURE 122 0.0040
252 ATELECTASIS 39 0.0040
253 CHILLS 471 0.0040
254 HAIR COLOUR CHANGES 50 0.0040
255 GOUT 72 0.0040
256 DIABETES MELLITUS 304 0.0040
257 TYPE 2 DIABETES MELLITUS 134 0.0040
258 JOINT DISLOCATION 42 0.0040
259 ROTATOR CUFF SYNDROME 51 0.0040
260 EXOSTOSIS 36 0.0039
261 DECREASED APPETITE 914 0.0039
262 OSTEOARTHRITIS 166 0.0039
263 INITIAL INSOMNIA 40 0.0039
264 TASTE DISORDER 79 0.0039
265 ANAL INCONTINENCE 35 0.0039
266 TENDON RUPTURE 48 0.0039
267 HAEMATOCRIT DECREASED 77 0.0039
268 RED BLOOD CELL COUNT DECREASED 111 0.0039
269 HYPERKALAEMIA 136 0.0039
270 HYPERGLYCAEMIA 141 0.0039
271 ANGINA UNSTABLE 25 0.0038
272 MULTIPLE FRACTURES 63 0.0038
273 EOSINOPHILIA 67 0.0038
274 TRANSAMINASES INCREASED 85 0.0038
275 EJECTION FRACTION DECREASED 59 0.0038
276 NEPHROLITHIASIS 174 0.0038
277 WALKING AID USER 25 0.0038
278 BLOOD GLUCOSE DECREASED 182 0.0038
279 BOWEL MOVEMENT IRREGULARITY 29 0.0038
280 DEHYDRATION 505 0.0038
281 ANGINA PECTORIS 108 0.0038
282 ABDOMINAL PAIN UPPER 776 0.0038
283 THYROID DISORDER 58 0.0038
284 ALANINE AMINOTRANSFERASE INCREASED 231 0.0038
285 ATRIAL FLUTTER 30 0.0038
286 RENAL DISORDER 174 0.0037
287 ACUTE MYELOID LEUKAEMIA 58 0.0037
288 EYE INFECTION 42 0.0037
289 CARDIAC FLUTTER 24 0.0037
290 DIZZINESS POSTURAL 36 0.0037
291 CHOLANGITIS 23 0.0037
292 HIATUS HERNIA 48 0.0037
293 INCREASED TENDENCY TO BRUISE 34 0.0037
294 ABDOMINAL PAIN 859 0.0037
295 URINARY INCONTINENCE 109 0.0037
296 PERICARDIAL EFFUSION 85 0.0037
297 MALNUTRITION 41 0.0037
298 DIALYSIS 52 0.0037
299 BLOOD GLUCOSE INCREASED 690 0.0037
300 HYPONATRAEMIA 206 0.0037
301 GASTROENTERITIS VIRAL 66 0.0037
302 RECTAL HAEMORRHAGE 157 0.0037
303 BASAL CELL CARCINOMA 57 0.0036
304 BLOOD CALCIUM INCREASED 32 0.0036
305 NEPHROTIC SYNDROME 25 0.0036
306 ECCHYMOSIS 25 0.0036
307 SINUSITIS 373 0.0036
308 THIRST 65 0.0036
309 BRONCHITIS 269 0.0036
310 NEUROLEPTIC MALIGNANT SYNDROME 43 0.0036
311 BLOOD PRESSURE FLUCTUATION 87 0.0036
312 HERNIA 70 0.0036
313 HEPATIC CIRRHOSIS 68 0.0036
314 LIVER FUNCTION TEST ABNORMAL 105 0.0036
315 FOOT DEFORMITY 40 0.0036
316 FLATULENCE 204 0.0036
317 ATRIAL FIBRILLATION 350 0.0036
318 HYPOTHYROIDISM 114 0.0036
319 TOOTH INFECTION 47 0.0036
320 ASTHENIA 1336 0.0035
321 PAPULE 25 0.0035
322 MELAENA 78 0.0035
323 HOSPICE CARE 35 0.0035
324 LIGAMENT SPRAIN 35 0.0035
325 SKIN LESION 97 0.0035
326 HYPOPHAGIA 90 0.0035
327 INCREASED APPETITE 67 0.0035
328 BACK DISORDER 57 0.0035
329 DRUG LEVEL INCREASED 58 0.0035
330 HEPATOTOXICITY 78 0.0035
331 MULTIPLE ORGAN DYSFUNCTION SYNDROME 99 0.0035
332 PULMONARY EMBOLISM 332 0.0035
333 SEPTIC SHOCK 152 0.0035
334 DYSGRAPHIA 23 0.0035
335 ANURIA 30 0.0035
336 WEIGHT DECREASED 971 0.0035
337 POLLAKIURIA 145 0.0035
338 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 27 0.0035
339 BLOOD GLUCOSE FLUCTUATION 38 0.0035
340 HAEMODIALYSIS 29 0.0034
341 PETECHIAE 36 0.0034
342 ORTHOSTATIC HYPOTENSION 60 0.0034
343 ACUTE RESPIRATORY FAILURE 66 0.0034
344 DIARRHOEA HAEMORRHAGIC 32 0.0034
345 GROIN PAIN 30 0.0034
346 CARDIOMEGALY 42 0.0034
347 ERUCTATION 66 0.0034
348 FURUNCLE 27 0.0034
349 HAEMATOMA 88 0.0034
350 ACUTE RESPIRATORY DISTRESS SYNDROME 60 0.0034
351 LIVER DISORDER 150 0.0034
352 HEAD INJURY 107 0.0034
353 SOMNOLENCE 680 0.0034
354 POISONING DELIBERATE 32 0.0034
355 PHARYNGEAL SWELLING 33 0.0034
356 DYSPNOEA EXERTIONAL 127 0.0034
357 COAGULOPATHY 56 0.0034
358 IRON DEFICIENCY ANAEMIA 31 0.0034
359 MYOCLONUS 40 0.0034
360 COUGH 939 0.0033
361 WEIGHT FLUCTUATION 35 0.0033
362 KETOACIDOSIS 25 0.0033
363 INSOMNIA 888 0.0033
364 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 25 0.0033
365 CHOLECYSTECTOMY 38 0.0033
366 DIARRHOEA 2144 0.0033
367 NEUTROPHIL COUNT INCREASED 34 0.0033
368 BLOOD PRESSURE ABNORMAL 66 0.0033
369 MYOCARDITIS 38 0.0033
370 URINARY TRACT INFECTION 564 0.0033
371 HYPOKINESIA 48 0.0033
372 GASTRITIS 87 0.0033
373 FORMICATION 23 0.0033
374 PULMONARY THROMBOSIS 36 0.0033
375 FEELING HOT 202 0.0033
376 BLOOD POTASSIUM DECREASED 99 0.0033
377 SINUS DISORDER 65 0.0033
378 CHROMATURIA 74 0.0033
379 PURPURA 29 0.0033
380 CARDIOGENIC SHOCK 47 0.0033
381 STAPHYLOCOCCAL INFECTION 108 0.0033
382 ERECTILE DYSFUNCTION 84 0.0033
383 HOT FLUSH 246 0.0033
384 BLOOD THYROID STIMULATING HORMONE INCREASED 30 0.0033
385 LEUKOCYTOSIS 59 0.0033
386 ORAL PAIN 73 0.0033
387 INFUSION SITE PAIN 42 0.0033
388 SMALL INTESTINAL OBSTRUCTION 40 0.0032
389 HAND FRACTURE 23 0.0032
390 DERMATITIS CONTACT 37 0.0032
391 INTERNAL HAEMORRHAGE 37 0.0032
392 SEROTONIN SYNDROME 62 0.0032
393 CONSTIPATION 703 0.0032
394 GASTROENTERITIS 47 0.0032
395 DYSSTASIA 94 0.0032
396 ILEUS 40 0.0032
397 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 33 0.0032
398 MIDDLE INSOMNIA 60 0.0032
399 HEPATIC ENZYME INCREASED 219 0.0032
400 SKIN ULCER 83 0.0032
401 RESPIRATORY TRACT CONGESTION 51 0.0032
402 AGEUSIA 80 0.0032
403 DYSURIA 118 0.0032
404 PROSTATIC SPECIFIC ANTIGEN INCREASED 44 0.0032
405 VENTRICULAR EXTRASYSTOLES 33 0.0032
406 CLOSTRIDIUM DIFFICILE INFECTION 69 0.0032
407 INTESTINAL OBSTRUCTION 119 0.0032
408 DELUSION 49 0.0032
409 TOOTH ABSCESS 32 0.0031
410 CARDIAC OPERATION 27 0.0031
411 MUSCULOSKELETAL DISCOMFORT 54 0.0031
412 COVID-19 PNEUMONIA 37 0.0031
413 PSYCHOLOGICAL TRAUMA 27 0.0031
414 RENAL PAIN 33 0.0031
415 HAEMOLYSIS 24 0.0031
416 LOCALISED INFECTION 75 0.0031
417 HYPERBILIRUBINAEMIA 32 0.0031
418 OXYGEN SATURATION DECREASED 173 0.0031
419 CELLULITIS 155 0.0031
420 VISION BLURRED 422 0.0031
421 RESPIRATORY TRACT INFECTION 80 0.0031
422 LIMB DISCOMFORT 95 0.0031
423 PRURITUS 1177 0.0031
424 BRAIN FOG 48 0.0031
425 NERVE INJURY 34 0.0031
426 OROPHARYNGEAL PAIN 283 0.0031
427 ARTERIAL OCCLUSIVE DISEASE 24 0.0031
428 MUSCULAR WEAKNESS 347 0.0031
429 C-REACTIVE PROTEIN INCREASED 111 0.0030
430 DRUG ERUPTION 54 0.0030
431 ESCHERICHIA INFECTION 25 0.0030
432 HAIR DISORDER 25 0.0030
433 BLOOD COUNT ABNORMAL 46 0.0030
434 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 78 0.0030
435 MUSCLE SPASMS 555 0.0030
436 OEDEMA 164 0.0030
437 CYSTITIS 96 0.0030
438 UPPER LIMB FRACTURE 60 0.0030
439 FOOT FRACTURE 57 0.0030
440 PRURITUS GENERALISED 65 0.0030
441 OEDEMA PERIPHERAL 366 0.0030
442 FAECES DISCOLOURED 65 0.0030
443 TRANSIENT ISCHAEMIC ATTACK 101 0.0030
444 CYST 37 0.0030
445 NOCTURIA 36 0.0030
446 RIB FRACTURE 61 0.0030
447 SKIN PLAQUE 25 0.0030
448 DYSPEPSIA 291 0.0030
449 OSTEOPOROSIS 121 0.0029
450 SUBDURAL HAEMATOMA 42 0.0029
451 EAR INFECTION 78 0.0029
452 SPINAL OPERATION 36 0.0029
453 WHITE BLOOD CELL COUNT INCREASED 112 0.0029
454 RETCHING 62 0.0029
455 ANKLE FRACTURE 45 0.0029
456 BACK PAIN 675 0.0029
457 ANAEMIA 554 0.0029
458 MYELODYSPLASTIC SYNDROME 42 0.0029
459 BLOOD LACTATE DEHYDROGENASE INCREASED 46 0.0029
460 MUSCULOSKELETAL PAIN 152 0.0029
461 CONTUSION 279 0.0029
462 HAEMOGLOBIN DECREASED 297 0.0029
463 ARTHRALGIA 1202 0.0029
464 LYMPHADENOPATHY 102 0.0029
465 PULMONARY OEDEMA 129 0.0029
466 PRODUCT TASTE ABNORMAL 39 0.0029
467 PSORIASIS 376 0.0029
468 DECREASED ACTIVITY 31 0.0029
469 RESTLESS LEGS SYNDROME 52 0.0029
470 GAIT DISTURBANCE 547 0.0029
471 BALANCE DISORDER 247 0.0029
472 SENSORY LOSS 23 0.0029
473 LUNG DISORDER 140 0.0029
474 DRUG LEVEL DECREASED 29 0.0028
475 NECK PAIN 159 0.0028
476 FATIGUE 2211 0.0028
477 OESOPHAGITIS 31 0.0028
478 WRIST FRACTURE 34 0.0028
479 MALIGNANT MELANOMA 38 0.0028
480 NODULE 37 0.0028
481 FEBRILE NEUTROPENIA 188 0.0028
482 DIZZINESS 1409 0.0028
483 DRY MOUTH 229 0.0028
484 JOINT STIFFNESS 74 0.0028
485 GASTROINTESTINAL PAIN 31 0.0028
486 INSURANCE ISSUE 43 0.0028
487 PERIPHERAL SWELLING 433 0.0028
488 FEEDING DISORDER 57 0.0028
489 ARTHRITIS 221 0.0028
490 CONFUSIONAL STATE 454 0.0028
491 LIMB INJURY 76 0.0028
492 HEART RATE DECREASED 98 0.0028
493 GASTROINTESTINAL INFECTION 25 0.0028
494 CATARACT 166 0.0028
495 RASH MACULO-PAPULAR 62 0.0028
496 HEPATIC ENCEPHALOPATHY 26 0.0028
497 INJECTION SITE MASS 103 0.0028
498 PLEURAL EFFUSION 169 0.0028
499 PAIN IN EXTREMITY 818 0.0028
500 CHEST PAIN 513 0.0028
501 PYELONEPHRITIS 24 0.0028
502 ABDOMINAL DISTENSION 289 0.0028
503 DYSPNOEA 1564 0.0028
504 SQUAMOUS CELL CARCINOMA 26 0.0028
505 SCIATICA 44 0.0028
506 EOSINOPHIL COUNT INCREASED 23 0.0028
507 QUALITY OF LIFE DECREASED 37 0.0028
508 RHINORRHOEA 178 0.0028
509 FLUID RETENTION 140 0.0027
510 CARDIAC FAILURE CONGESTIVE 221 0.0027
511 DISORIENTATION 109 0.0027
512 MOTOR DYSFUNCTION 28 0.0027
513 BODY TEMPERATURE DECREASED 27 0.0027
514 PSORIATIC ARTHROPATHY 111 0.0027
515 VENTRICULAR TACHYCARDIA 45 0.0027
516 BLISTER 153 0.0027
517 MASS 38 0.0027
518 HYPERHIDROSIS 350 0.0027
519 SCHIZOPHRENIA 33 0.0027
520 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 24 0.0027
521 NEURALGIA 66 0.0027
522 HYPERTENSION 574 0.0027
523 DYSARTHRIA 102 0.0027
524 BLOOD SODIUM DECREASED 51 0.0027
525 NASAL CONGESTION 159 0.0027
526 AFFECT LABILITY 26 0.0027
527 KIDNEY INFECTION 53 0.0027
528 BLOOD PRESSURE DECREASED 179 0.0027
529 COLITIS 102 0.0027
530 ISCHAEMIC STROKE 48 0.0027
531 LIVER INJURY 66 0.0027
532 HAEMOPTYSIS 75 0.0027
533 UPPER RESPIRATORY TRACT INFECTION 124 0.0027
534 HYPOTENSION 536 0.0027
535 PHARYNGITIS 33 0.0027
536 LACERATION 25 0.0027
537 CARDIAC MURMUR 23 0.0027
538 DYSKINESIA 108 0.0027
539 SCRATCH 28 0.0027
540 HYPERSOMNIA 76 0.0026
541 SLEEP DISORDER 187 0.0026
542 VOMITING 1244 0.0026
543 ADRENAL INSUFFICIENCY 32 0.0026
544 NAUSEA 2077 0.0026
545 DELIRIUM 91 0.0026
546 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 25 0.0026
547 BLOOD ALKALINE PHOSPHATASE INCREASED 65 0.0026
548 VIRAL INFECTION 87 0.0026
549 ORAL HERPES 51 0.0026
550 PAIN IN JAW 74 0.0026
551 FUNGAL INFECTION 87 0.0026
552 ABDOMINAL PAIN LOWER 66 0.0026
553 JOINT RANGE OF MOTION DECREASED 35 0.0026
554 LABORATORY TEST ABNORMAL 77 0.0026
555 LETHARGY 150 0.0026
556 CANDIDA INFECTION 44 0.0026
557 LOWER LIMB FRACTURE 50 0.0026
558 RASH PRURITIC 141 0.0026
559 WHITE BLOOD CELL COUNT DECREASED 282 0.0026
560 UROSEPSIS 24 0.0026
561 POOR QUALITY SLEEP 56 0.0026
562 TREMOR 431 0.0026
563 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 135 0.0026
564 HYPOXIA 91 0.0026
565 PYREXIA 894 0.0026
566 DYSPHONIA 151 0.0026
567 DEPRESSION 587 0.0026
568 EMPHYSEMA 26 0.0026
569 EAR PAIN 50 0.0026
570 FEELING JITTERY 49 0.0026
571 WEIGHT INCREASED 575 0.0026
572 NERVOUSNESS 134 0.0026
573 THROMBOSIS 206 0.0026
574 VERTIGO 156 0.0026
575 DEEP VEIN THROMBOSIS 166 0.0026
576 FULL BLOOD COUNT ABNORMAL 27 0.0026
577 NEUTROPENIA 347 0.0025
578 ANAPHYLACTIC REACTION 141 0.0025
579 SLUGGISHNESS 26 0.0025
580 CLOSTRIDIUM DIFFICILE COLITIS 27 0.0025
581 NIGHTMARE 88 0.0025
582 HAIR TEXTURE ABNORMAL 34 0.0025
583 HEADACHE 1589 0.0025
584 DRUG INTOLERANCE 244 0.0025
585 HERPES ZOSTER 144 0.0025
586 CARDIAC FAILURE 201 0.0025
587 TACHYPNOEA 34 0.0025
588 EYELID OEDEMA 29 0.0025
589 INTESTINAL PERFORATION 28 0.0025
590 ABDOMINAL DISCOMFORT 418 0.0025
591 DISSEMINATED INTRAVASCULAR COAGULATION 35 0.0025
592 OSTEOMYELITIS 45 0.0025
593 BIPOLAR DISORDER 27 0.0025
594 JOINT INJURY 53 0.0025
595 CONJUNCTIVITIS 46 0.0025
596 PRODUCT PHYSICAL ISSUE 50 0.0025
597 BRADYCARDIA 131 0.0025
598 KNEE ARTHROPLASTY 52 0.0025
599 MUSCLE TIGHTNESS 40 0.0025
600 PRODUCT DOSE OMISSION 161 0.0025
601 ERYTHEMA MULTIFORME 23 0.0025
602 MALAISE 1080 0.0025
603 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 118 0.0025
604 ANXIETY 699 0.0025
605 RASH PAPULAR 55 0.0025
606 THROAT IRRITATION 110 0.0024
607 MENTAL STATUS CHANGES 68 0.0024
608 SPINAL FRACTURE 49 0.0024
609 ABSCESS 39 0.0024
610 ATAXIA 29 0.0024
611 FREQUENT BOWEL MOVEMENTS 66 0.0024
612 KNEE OPERATION 24 0.0024
613 BEDRIDDEN 32 0.0024
614 FACE OEDEMA 41 0.0024
615 MEMORY IMPAIRMENT 334 0.0024
616 URINARY RETENTION 81 0.0024
617 HYPERTENSIVE CRISIS 27 0.0024
618 MYOCARDIAL INFARCTION 423 0.0024
619 BLOOD URINE PRESENT 46 0.0024
620 EPISTAXIS 181 0.0024
621 GALLBLADDER DISORDER 43 0.0024
622 BLOOD CALCIUM DECREASED 27 0.0024
623 TENDERNESS 25 0.0024
624 EYE HAEMORRHAGE 32 0.0024
625 SCAR 41 0.0024
626 HIP FRACTURE 77 0.0024
627 HALLUCINATION, AUDITORY 38 0.0024
628 NIGHT SWEATS 77 0.0024
629 NEUROPATHY PERIPHERAL 227 0.0024
630 APHASIA 72 0.0024
631 MYOCARDIAL ISCHAEMIA 27 0.0024
632 FEELING COLD 66 0.0024
633 MUCOSAL INFLAMMATION 62 0.0024
634 GASTRIC ULCER 45 0.0024
635 INFLUENZA 264 0.0024
636 PRODUCT DOSE OMISSION IN ERROR 67 0.0024
637 IMPAIRED QUALITY OF LIFE 34 0.0024
638 LOSS OF CONSCIOUSNESS 303 0.0024
639 MICTURITION URGENCY 27 0.0024
640 BONE MARROW FAILURE 48 0.0024
641 ENCEPHALOPATHY 58 0.0024
642 THINKING ABNORMAL 44 0.0024
643 GASTROINTESTINAL DISORDER 209 0.0023
644 ANOREXIA 30 0.0023
645 MADAROSIS 27 0.0023
646 TREATMENT NONCOMPLIANCE 127 0.0023
647 PLATELET COUNT DECREASED 247 0.0023
648 PALLOR 63 0.0023
649 PROCEDURAL PAIN 64 0.0023
650 EATING DISORDER 49 0.0023
651 RASH ERYTHEMATOUS 110 0.0023
652 PNEUMONIA 743 0.0023
653 POST PROCEDURAL COMPLICATION 44 0.0023
654 PAIN 1407 0.0023
655 PANCYTOPENIA 128 0.0023
656 HAEMATOCHEZIA 126 0.0023
657 FULL BLOOD COUNT DECREASED 46 0.0023
658 METASTASES TO LIVER 40 0.0023
659 GASTRIC DISORDER 78 0.0023
660 FIBROMYALGIA 55 0.0023
661 THERAPY CESSATION 116 0.0023
662 LACRIMATION INCREASED 68 0.0022
663 INTENTIONAL DOSE OMISSION 64 0.0022
664 DERMATITIS 47 0.0022
665 ILLNESS 231 0.0022
666 PRODUCTIVE COUGH 107 0.0022
667 ARTHROPATHY 124 0.0022
668 NASOPHARYNGITIS 410 0.0022
669 PRESCRIBED OVERDOSE 43 0.0022
670 HIP ARTHROPLASTY 34 0.0022
671 PARAESTHESIA 349 0.0022
672 HEART RATE IRREGULAR 50 0.0022
673 MENTAL DISORDER 96 0.0022
674 PARANOIA 38 0.0022
675 EYE SWELLING 82 0.0022
676 IMMUNE SYSTEM DISORDER 29 0.0022
677 PREMATURE DELIVERY 35 0.0022
678 WHEEZING 130 0.0022
679 HALLUCINATION 165 0.0022
680 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 51 0.0022
681 GAIT INABILITY 73 0.0022
682 COMPLETED SUICIDE 182 0.0022
683 DRY EYE 109 0.0022
684 SKIN CANCER 47 0.0022
685 DYSGEUSIA 162 0.0022
686 NEOPLASM 25 0.0022
687 SUDDEN DEATH 23 0.0022
688 ABNORMAL DREAMS 60 0.0022
689 BURNING SENSATION 152 0.0022
690 SURGERY 127 0.0022
691 FEELING ABNORMAL 518 0.0022
692 THERAPY INTERRUPTED 154 0.0022
693 APHONIA 30 0.0021
694 SKIN FISSURES 42 0.0021
695 HEREDITARY ANGIOEDEMA 23 0.0021
696 BURSITIS 26 0.0021
697 THERAPEUTIC RESPONSE UNEXPECTED 96 0.0021
698 SPINAL PAIN 25 0.0021
699 INFLAMMATION 110 0.0021
700 GLAUCOMA 41 0.0021
701 SKIN DISORDER 71 0.0021
702 BLINDNESS UNILATERAL 30 0.0021
703 ORAL CANDIDIASIS 28 0.0021
704 PULMONARY CONGESTION 28 0.0021
705 BONE PAIN 124 0.0021
706 THERAPY PARTIAL RESPONDER 33 0.0021
707 HEART RATE INCREASED 209 0.0021
708 ROAD TRAFFIC ACCIDENT 88 0.0021
709 ASPIRATION 23 0.0021
710 HYPOAESTHESIA 314 0.0021
711 MACULAR DEGENERATION 25 0.0021
712 PNEUMONITIS 57 0.0021
713 SKIN HAEMORRHAGE 31 0.0021
714 SWELLING FACE 136 0.0021
715 LEUKOPENIA 104 0.0021
716 JOINT SWELLING 249 0.0021
717 IRRITABLE BOWEL SYNDROME 44 0.0021
718 COVID-19 360 0.0020
719 SWELLING 192 0.0020
720 SKIN INFECTION 23 0.0020
721 MOBILITY DECREASED 147 0.0020
722 TOOTHACHE 37 0.0020
723 DEMENTIA 57 0.0020
724 BACTERIAL INFECTION 38 0.0020
725 CONDITION AGGRAVATED 617 0.0020
726 DEAFNESS 53 0.0020
727 IMPAIRED DRIVING ABILITY 23 0.0020
728 DYSPHAGIA 192 0.0020
729 PNEUMOTHORAX 32 0.0020
730 SCAB 23 0.0020
731 PULMONARY HYPERTENSION 42 0.0020
732 RESPIRATORY FAILURE 147 0.0020
733 ULCER 32 0.0020
734 CARDIAC ARREST 166 0.0020
735 SNEEZING 45 0.0020
736 POLYNEUROPATHY 24 0.0020
737 TENDONITIS 31 0.0020
738 AGITATION 147 0.0020
739 AMNESIA 130 0.0020
740 MUSCULOSKELETAL STIFFNESS 175 0.0020
741 NEUROTOXICITY 35 0.0020
742 MUSCULOSKELETAL DISORDER 38 0.0020
743 DRUG DOSE OMISSION 330 0.0020
744 MOVEMENT DISORDER 64 0.0020
745 BLOOD TEST ABNORMAL 28 0.0020
746 ANGIOEDEMA 88 0.0020
747 INTERSTITIAL LUNG DISEASE 96 0.0020
748 LYMPHOCYTE COUNT DECREASED 35 0.0020
749 ELECTROLYTE IMBALANCE 23 0.0020
750 TOXIC EPIDERMAL NECROLYSIS 30 0.0020
751 SINUS TACHYCARDIA 28 0.0020
752 ACTIVITIES OF DAILY LIVING IMPAIRED 39 0.0020
753 SARS-COV-2 TEST POSITIVE 26 0.0020
754 MULTI-ORGAN FAILURE 34 0.0020
755 CEREBROVASCULAR ACCIDENT 333 0.0020
756 BODY TEMPERATURE INCREASED 40 0.0020
757 NEEDLE ISSUE 57 0.0020
758 CARDIAC DISORDER 183 0.0020
759 CRYING 71 0.0020
760 MUSCLE TWITCHING 45 0.0020
761 PHARYNGEAL OEDEMA 30 0.0019
762 LOCAL SWELLING 34 0.0019
763 COLON CANCER 29 0.0019
764 IMMUNODEFICIENCY 29 0.0019
765 HALLUCINATION, VISUAL 41 0.0019
766 GENERALISED TONIC-CLONIC SEIZURE 32 0.0019
767 STOMATITIS 117 0.0019
768 IRRITABILITY 116 0.0019
769 PRODUCT DOSE OMISSION ISSUE 567 0.0019
770 INTENTIONAL PRODUCT MISUSE 168 0.0019
771 SPEECH DISORDER 100 0.0019
772 DERMATITIS ALLERGIC 24 0.0019
773 CYANOSIS 30 0.0019
774 GINGIVAL BLEEDING 26 0.0019
775 HYPOCALCAEMIA 36 0.0019
776 MOUTH ULCERATION 40 0.0019
777 INFLUENZA LIKE ILLNESS 156 0.0019
778 SWOLLEN TONGUE 59 0.0019
779 GENERAL PHYSICAL HEALTH DETERIORATION 218 0.0019
780 BONE DENSITY DECREASED 59 0.0019
781 PALPITATIONS 220 0.0019
782 PULMONARY FIBROSIS 36 0.0019
783 CHEST DISCOMFORT 192 0.0019
784 MOOD ALTERED 51 0.0019
785 HUNGER 26 0.0019
786 RASH 813 0.0019
787 ERYTHEMA 383 0.0019
788 MENTAL IMPAIRMENT 45 0.0019
789 INJECTION SITE HAEMORRHAGE 148 0.0019
790 LOWER RESPIRATORY TRACT INFECTION 84 0.0018
791 THERAPY NON-RESPONDER 83 0.0018
792 PLATELET COUNT INCREASED 24 0.0018
793 TOXICITY TO VARIOUS AGENTS 310 0.0018
794 PRODUCT ADMINISTRATION ERROR 37 0.0018
795 MANIA 30 0.0018
796 DRUG PRESCRIBING ERROR 35 0.0018
797 INJECTION SITE BRUISING 145 0.0018
798 LIVER FUNCTION TEST INCREASED 39 0.0018
799 PARALYSIS 26 0.0018
800 MIGRAINE 173 0.0018
801 PNEUMONIA ASPIRATION 45 0.0018
802 ORAL DISCOMFORT 25 0.0018
803 CHOKING 35 0.0018
804 PANIC ATTACK 65 0.0018
805 RESPIRATORY DISTRESS 49 0.0018
806 DISTURBANCE IN ATTENTION 95 0.0018
807 PRESCRIBED UNDERDOSE 35 0.0018
808 ARRHYTHMIA 83 0.0018
809 CONTRAINDICATED PRODUCT ADMINISTERED 53 0.0017
810 DISEASE RECURRENCE 83 0.0017
811 ALOPECIA 342 0.0017
812 BLOOD BILIRUBIN INCREASED 47 0.0017
813 ECZEMA 91 0.0017
814 HAEMORRHAGE INTRACRANIAL 26 0.0017
815 IMPAIRED HEALING 57 0.0017
816 COGNITIVE DISORDER 81 0.0017
817 UNEVALUABLE EVENT 131 0.0017
818 PULMONARY ARTERIAL HYPERTENSION 25 0.0017
819 DISCOMFORT 105 0.0017
820 ANGER 58 0.0017
821 LIP SWELLING 57 0.0017
822 COLD SWEAT 30 0.0017
823 INTENTIONAL PRODUCT USE ISSUE 149 0.0017
824 SHOCK 39 0.0017
825 DEVICE RELATED INFECTION 26 0.0017
826 SKIN EXFOLIATION 142 0.0017
827 BRONCHOSPASM 24 0.0017
828 UNRESPONSIVE TO STIMULI 43 0.0017
829 INFECTION 241 0.0017
830 PARAESTHESIA ORAL 24 0.0017
831 SEIZURE 192 0.0017
832 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 118 0.0017
833 HYPERTHYROIDISM 24 0.0017
834 DISEASE PROGRESSION 196 0.0017
835 EMOTIONAL DISTRESS 200 0.0017
836 WRONG TECHNIQUE IN DRUG USAGE PROCESS 60 0.0016
837 FLUID OVERLOAD 24 0.0016
838 COORDINATION ABNORMAL 23 0.0016
839 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 28 0.0016
840 NEUTROPHIL COUNT DECREASED 67 0.0016
841 RESPIRATORY DISORDER 49 0.0016
842 OFF LABEL USE 1421 0.0016
843 WITHDRAWAL SYNDROME 68 0.0016
844 TOOTH DISORDER 36 0.0016
845 ELECTROCARDIOGRAM QT PROLONGED 58 0.0016
846 EYE DISORDER 53 0.0016
847 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 88 0.0016
848 RASH MACULAR 56 0.0016
849 DYSTONIA 31 0.0016
850 DRUG EFFECT INCOMPLETE 58 0.0016
851 DRUG ADMINISTRATION ERROR 49 0.0016
852 PELVIC PAIN 29 0.0016
853 HEMIPARESIS 27 0.0016
854 DEPRESSED MOOD 84 0.0016
855 RESTLESSNESS 58 0.0016
856 METASTASES TO BONE 26 0.0016
857 RASH GENERALISED 41 0.0016
858 PRODUCT AVAILABILITY ISSUE 36 0.0016
859 EYE PRURITUS 53 0.0016
860 WOUND 44 0.0016
861 HAEMORRHAGE 164 0.0016
862 INJECTION SITE PRURITUS 105 0.0016
863 THROMBOCYTOPENIA 175 0.0016
864 FEAR 42 0.0016
865 PRODUCT PRESCRIBING ISSUE 34 0.0016
866 SENSORY DISTURBANCE 25 0.0016
867 EMOTIONAL DISORDER 48 0.0016
868 INFUSION RELATED REACTION 103 0.0016
869 PERICARDITIS 26 0.0015
870 PRODUCT SUBSTITUTION ISSUE 89 0.0015
871 SKIN DISCOLOURATION 71 0.0015
872 SUICIDAL IDEATION 141 0.0015
873 AGGRESSION 77 0.0015
874 EPILEPSY 47 0.0015
875 CEREBRAL HAEMORRHAGE 55 0.0015
876 VISUAL ACUITY REDUCED 51 0.0015
877 INJECTION SITE PAIN 467 0.0015
878 EYE IRRITATION 87 0.0015
879 UNDERDOSE 110 0.0015
880 PRODUCT USE IN UNAPPROVED INDICATION 366 0.0015
881 PRODUCT QUALITY ISSUE 200 0.0015
882 ASTHMA 166 0.0015
883 ABNORMAL BEHAVIOUR 58 0.0015
884 HYPOACUSIS 63 0.0015
885 VISUAL IMPAIRMENT 180 0.0015
886 SEDATION 38 0.0014
887 PRODUCT USE ISSUE 272 0.0014
888 NERVOUS SYSTEM DISORDER 45 0.0014
889 BONE DISORDER 26 0.0014
890 FRACTURE 27 0.0014
891 INJURY 99 0.0014
892 DRUG INEFFECTIVE 1834 0.0014
893 OCULAR HYPERAEMIA 66 0.0014
894 PANCREATIC CARCINOMA 40 0.0014
895 HOSPITALISATION 212 0.0014
896 HYPERSENSITIVITY 256 0.0014
897 URTICARIA 230 0.0014
898 EXTRAPYRAMIDAL DISORDER 34 0.0014
899 CONVULSION 78 0.0014
900 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 245 0.0014
901 MULTIPLE SCLEROSIS 65 0.0014
902 PERITONITIS 28 0.0014
903 TARDIVE DYSKINESIA 38 0.0013
904 DEPRESSED LEVEL OF CONSCIOUSNESS 53 0.0013
905 DRUG EFFECT DECREASED 72 0.0013
906 ABASIA 33 0.0013
907 ILL-DEFINED DISORDER 81 0.0013
908 PREMATURE BABY 40 0.0013
909 FEMUR FRACTURE 41 0.0013
910 INCORRECT DOSE ADMINISTERED 302 0.0013
911 INCORRECT DRUG ADMINISTRATION DURATION 37 0.0013
912 IMPAIRED WORK ABILITY 28 0.0013
913 CARDIOVASCULAR DISORDER 33 0.0013
914 GLOSSODYNIA 29 0.0013
915 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 92 0.0013
916 MOOD SWINGS 41 0.0013
917 ANAPHYLACTIC SHOCK 33 0.0013
918 MALIGNANT NEOPLASM PROGRESSION 131 0.0013
919 SUICIDE ATTEMPT 77 0.0013
920 CEREBRAL INFARCTION 31 0.0013
921 DRY SKIN 169 0.0013
922 LUNG NEOPLASM MALIGNANT 52 0.0013
923 INJECTION SITE SWELLING 95 0.0012
924 EXPIRED PRODUCT ADMINISTERED 41 0.0012
925 PRODUCT ADHESION ISSUE 44 0.0012
926 ACCIDENTAL OVERDOSE 45 0.0012
927 SKIN BURNING SENSATION 88 0.0012
928 APPLICATION SITE PAIN 27 0.0012
929 THROAT TIGHTNESS 33 0.0012
930 RHEUMATOID ARTHRITIS 138 0.0012
931 DEVICE MALFUNCTION 85 0.0012
932 MEDICATION ERROR 67 0.0012
933 INCORRECT PRODUCT ADMINISTRATION DURATION 26 0.0012
934 CYTOKINE RELEASE SYNDROME 24 0.0012
935 THERAPEUTIC RESPONSE DECREASED 72 0.0012
936 DEVICE ISSUE 104 0.0012
937 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 230 0.0011
938 DRUG RESISTANCE 29 0.0011
939 THERAPEUTIC PRODUCT EFFECT DECREASED 50 0.0011
940 INJECTION SITE REACTION 76 0.0011
941 PLASMA CELL MYELOMA 43 0.0011
942 PRODUCT DISPENSING ERROR 24 0.0011
943 INJECTION SITE URTICARIA 27 0.0011
944 DERMATITIS ATOPIC 58 0.0011
945 COLITIS ULCERATIVE 49 0.0011
946 PRODUCT PRESCRIBING ERROR 26 0.0011
947 ADVERSE DRUG REACTION 98 0.0011
948 STEVENS-JOHNSON SYNDROME 24 0.0011
949 APPLICATION SITE ERYTHEMA 28 0.0011
950 INCORRECT DOSE ADMINISTERED BY DEVICE 28 0.0011
951 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 36 0.0011
952 MULTIPLE SCLEROSIS RELAPSE 73 0.0011
953 INJECTION SITE ERYTHEMA 132 0.0011
954 THERAPEUTIC RESPONSE SHORTENED 35 0.0011
955 EXPOSURE DURING PREGNANCY 65 0.0010
956 DEVICE LEAKAGE 44 0.0010
957 OSTEONECROSIS OF JAW 25 0.0010
958 NEOPLASM PROGRESSION 35 0.0010
959 DEATH 863 0.0010
960 RESPIRATORY ARREST 27 0.0010
961 GYNAECOMASTIA 30 0.0010
962 PSYCHOTIC DISORDER 28 0.0009
963 OVERDOSE 199 0.0009
964 MYELOSUPPRESSION 33 0.0009
965 NEOPLASM MALIGNANT 61 0.0009
966 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 42 0.0009
967 EXTRA DOSE ADMINISTERED 36 0.0009
968 EXPOSURE VIA SKIN CONTACT 23 0.0009
969 ADVERSE EVENT 76 0.0008
970 OSTEONECROSIS 27 0.0008
971 TREATMENT FAILURE 67 0.0008
972 SKIN IRRITATION 36 0.0008
973 DRUG WITHDRAWAL SYNDROME 66 0.0008
974 INJECTION SITE RASH 23 0.0007
975 INTENTIONAL OVERDOSE 48 0.0007
976 MATERNAL EXPOSURE DURING PREGNANCY 65 0.0007
977 SYSTEMIC LUPUS ERYTHEMATOSUS 24 0.0007
978 INCORRECT ROUTE OF DRUG ADMINISTRATION 24 0.0007
979 VAGINAL HAEMORRHAGE 29 0.0007
980 ACNE 50 0.0007
981 NO ADVERSE EVENT 119 0.0007
982 PRODUCT STORAGE ERROR 56 0.0006
983 PROSTATE CANCER 51 0.0006
984 FOETAL EXPOSURE DURING PREGNANCY 51 0.0006
985 ACCIDENTAL EXPOSURE TO PRODUCT 61 0.0006
986 RENAL CANCER 28 0.0006
987 ABORTION SPONTANEOUS 23 0.0006
988 DEVICE DIFFICULT TO USE 35 0.0005
989 BLADDER CANCER 31 0.0005
990 BREAST CANCER 41 0.0004
991 DRUG DOSE OMISSION BY DEVICE 30 0.0004
992 DRUG ABUSE 31 0.0004
993 DRUG DEPENDENCE 49 0.0003